News | September 12, 2022
Zenara Pharma launches the first generic of Paxlovid for COVID-19 in India
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
82.5% of patients treated at 10mg dose of obicetrapib achieved LDL-c target of <70 mg/dL, compared to 20% of patients treated with placebo
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
The product is expected to be available in a week’s time
Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)
Subscribe To Our Newsletter & Stay Updated
